OncoCyte (OCX) News Today → What is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners” (From Weiss Ratings) (Ad) Free OCX Stock Alerts $2.74 +0.09 (+3.40%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 31 at 5:00 AM | americanbankingnews.comOncoCyte (NASDAQ:OCX) Receives New Coverage from Analysts at StockNews.comMay 30 at 4:47 PM | globenewswire.comFavorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of MedicineMay 24, 2024 | americanbankingnews.comOncoCyte (NASDAQ:OCX) Coverage Initiated by Analysts at StockNews.comMay 16, 2024 | markets.businessinsider.comOncoCyte’s Strategic Initiatives and Financial Health Garner Buy RatingMay 16, 2024 | finanznachrichten.deOncoCyte Corporation: Oncocyte Reports First Quarter 2024 Financial ResultsMay 16, 2024 | finance.yahoo.comOncoCyte Corp (OCX) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ...May 16, 2024 | markets.businessinsider.com4 Analysts Assess OncoCyte: What You Need To KnowMay 16, 2024 | msn.comOncoCyte Corporation (NASDAQ:OCX) Q1 2024 Earnings Call TranscriptMay 15, 2024 | globenewswire.comOncocyte Reports First Quarter 2024 Financial ResultsMay 14, 2024 | msn.comOncoCyte Q1 2024 Earnings PreviewMay 13, 2024 | finance.yahoo.comOncocyte to Announce First Quarter 2024 Financial ResultsMay 7, 2024 | finance.yahoo.comPRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics MarketplaceMay 7, 2024 | insidertrades.com3 Penny Stocks That Insiders Are Buying (OCX)April 24, 2024 | markets.businessinsider.comStrong Future Outlook for OncoCyte: Buy Rating and Increased Price Target Amid Positive Partnerships and Financial EfficiencyApril 22, 2024 | msn.comBuffett Grabs More of This Stock, Plus Other Notable Insider BuyingApril 16, 2024 | insidertrades.comOncoCyte Co. (NASDAQ:OCX) CEO Buys $10,000.50 in StockApril 13, 2024 | seekingalpha.comOncoCyte Corporation (OCX) Q4 2023 Earnings Call TranscriptApril 13, 2024 | finance.yahoo.comQ4 2023 OncoCyte Corp Earnings CallApril 12, 2024 | investorplace.comOCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q4 2023April 12, 2024 | msn.comTop 3 Health Care Stocks That May Collapse In Q2April 12, 2024 | finanznachrichten.deOncoCyte Corporation: Oncocyte and Bio-Rad Partner on Global Launch of Transplant AssayApril 12, 2024 | msn.comS&P Futures Tick Lower as Investors Digest Big Bank EarningsApril 12, 2024 | msn.comS&P Futures Tick Lower as Investors Cautiously Await U.S. Big Bank EarningsApril 12, 2024 | msn.comOncocyte announces $15.8 mln private placement of securitiesApril 12, 2024 | globenewswire.comOncocyte Reports Full Year 2023 Financial ResultsApril 11, 2024 | globenewswire.comOncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq RulesApril 11, 2024 | globenewswire.comOncocyte and Bio-Rad Partner on Global Launch of Transplant AssayApril 11, 2024 | markets.businessinsider.comHere's what Wall Street expects from Oncocyte's earningsApril 9, 2024 | globenewswire.comOncocyte to Announce Fourth Quarter and Full Year 2024 Financial ResultsFebruary 29, 2024 | msn.comNeuroBo stock jumps 14% on weight-loss drug updateFebruary 24, 2024 | benzinga.comOncoCyte Stock (NASDAQ:OCX), Short Interest ReportJanuary 16, 2024 | finance.yahoo.comOncocyte to Present at the Sequire Investor Summit in Puerto RicoJanuary 7, 2024 | markets.businessinsider.comBTIG Reaffirms Their Hold Rating on OncoCyte (OCX)December 11, 2023 | benzinga.comOncoCyte Stock (NASDAQ:OCX) Dividends: History, Yield and DatesDecember 8, 2023 | marketbeat.comTrading was temporarily halted for "OCX" at 03:12 PM with a stated reason of "LULD pause."December 6, 2023 | finance.yahoo.comOncocyte Begins FDA Submissions Process for VitaGraft Transplant AssaysNovember 18, 2023 | morningstar.comOncoCyte Corp OCXNovember 10, 2023 | finance.yahoo.comOncoCyte Corporation (NASDAQ:OCX) Q3 2023 Earnings Call TranscriptNovember 9, 2023 | finance.yahoo.comOncoCyte Corp (OCX) Reports Q3 2023 Financial Results with Key Product Launches on the HorizonNovember 9, 2023 | finance.yahoo.comOncocyte Reports Third Quarter 2023 Financial ResultsNovember 3, 2023 | finance.yahoo.comOncocyte to Announce Third Quarter 2023 Financial ResultsSeptember 18, 2023 | finanznachrichten.deOncocyte Corporation: Oncocyte's VitaGraftTM Kidney Identifies Transplant Rejection 10 Months EarlierSeptember 18, 2023 | finance.yahoo.comOncocyte's VitaGraftTM Kidney Identifies Transplant Rejection 10 Months EarlierSeptember 6, 2023 | finance.yahoo.comOncocyte to Participate in the H.C. Wainwright 25th Annual Global Investment ConferenceAugust 28, 2023 | finanznachrichten.deOncocyte Corporation: Oncocyte's VitaGraft Kidney Transplant Diagnostic Test Receives CMS CoverageAugust 28, 2023 | finance.yahoo.comOncocyte's VitaGraft Kidney Transplant Diagnostic Test Receives CMS CoverageAugust 24, 2023 | nasdaq.comBenchmark Maintains Oncocyte (OCX) Speculative Buy RecommendationAugust 15, 2023 | msn.comPiper Sandler Maintains Oncocyte (OCX) Neutral RecommendationAugust 11, 2023 | msn.comNeedham Maintains Oncocyte (OCX) Buy RecommendationAugust 10, 2023 | finanznachrichten.deOncocyte Corporation: Oncocyte Reports Second Quarter 2023 Financial Results Get OncoCyte News Delivered to You Automatically Sign up to receive the latest news and ratings for OCX and its competitors with MarketBeat's FREE daily newsletter. Email Address Warren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector… (Ad)Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market… Click here for the details OCX Media Mentions By Week OCX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OCX News Sentiment▼0.630.76▲Average Medical News Sentiment OCX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OCX Articles This Week▼31▲OCX Articles Average Week Get OncoCyte News Delivered to You Automatically Sign up to receive the latest news and ratings for OCX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Achilles Therapeutics News DURECT News Alpha Teknova News VolitionRx News ARCA biopharma News ImmuCell News Aspira Women's Health News Cardio Diagnostics News Trinity Biotech News Biomerica News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OCX) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OncoCyte Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
